A new weekly jab thought to help people shed large amounts of body fat is being considered for wider use by the UK health service.Tirzepatide, from Eli Lilly and Company, is currently approved by regulators for type 2 diabetes but may soon also be approved for obesity.The National Institute for Health and Care Excellence (Nice) is seeing whether the drug sold under the brand name Mounjaro would be a good use of NHS funds.
[
add
]
[
|
|
...
]